HEATHER BLACK: Open Payments
NPI 1851717573 · NEW BERN, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$643 in 35 payments from 15 companies in 2025. Trend: 2023 $417 · 2024 $814 · 2025 $643
Food & beverage: $643
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 5 | $91 |
| GlaxoSmithKline, LLC. | 5 | $84 |
| Amgen Inc. | 5 | $79 |
| PFIZER INC. | 3 | $71 |
| Abbott Laboratories | 3 | $66 |
| Merck Sharp & Dohme LLC | 3 | $51 |
| AstraZeneca Pharmaceuticals LP | 2 | $38 |
| Lilly USA, LLC | 2 | $35 |
| Viatris Specialty LLC | 1 | $26 |
| Phathom Pharmaceuticals, Inc. | 1 | $22 |
Products named: TRELEGY ELLIPTA, OTEZLA, ELIQUIS, GARDASIL 9, Wegovy, FREESTYLE LIBRE 3, Ozempic, YUPELRI.
Industry payments across NC — which companies pay providers there.
